With so many choices out there, it's time to narrow the field.
*FDA approved for 2 to 3 times weekly dosing.
Once you've found a therapy with a twice-weekly dosing option* and ZERO spontaneous bleeds (median), other things can be taken into consideration.
Your AFSTYLA Connect Case Manager can help answer questions about insurance and get information you may need.
With more than 30 years of experience in bleeding disorders, CSL Behring remains committed to developing innovative therapies.
*FDA approved for dosing 2 to 3 times a week.
When you're ready to give AFSTYLA a try, simply print this form and give it to your doctor to request your free trial. All insured patients are eligible, including those covered by Medicare and Medicaid.
If you need assistance, speak with an AFSTYLA ConnectSM Case Manager 1-800-676-4266 Monday through Friday, 8 am to 8 pm ET.
